课题基金 / 基金详情

Elucidating ECM Signaling in Cardiac Organoids with Machine Learning and Single-cell Multiomics

Elucidating ECM Signaling in Cardiac Organoids with Machine Learning and Single-cell Multiomics
利用机器学习和单细胞多组学阐明心脏类器官中的 ECM 信号转导
批准号:
10435045
负责人:
JAYAKUMAR RAJADAS
金额:
$62.86万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-05-09 至 2026-04-30

项目摘要

项目成果

JAYAKUMAR RAJADAS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary Extracellular matrix (ECM) is the most abundant biomaterial in the body. During cardiac development, the ECM plays critical roles in the formation of shapes and patterns of the heart such as chambers and trabeculae through elaborate interactions with differentiating cells. Although problems in ECM-cell interactions can lead to heart diseases, signaling pathways activated by the specific ECM components are still poorly understood. We recently succeeded in developing human induced pluripotent stem cell-derived cardiac organoids (iPSC-COs) that can recapitulate cardiogenesis. In this multi-PI R01 proposal, our team will further elucidate the mechanisms of ECM- cell interactions that influence cardiac differentiation and morphogenesis. We will apply machine learning and novel iPSC double reporter lines (Tbx5-Clover2-Nkx2.5-TagRFP) to elucidate the effect of cell composition on morphogenesis of iPSC-COs (Aim 1). Afterwards, we will screen 36 different combinations of ECM compositions that can reliably induce iPSC-CO formation using 8 additional iPSC lines for validation (Aim 2). By rigorously analyzing iPSC-COs made with optimized ECM using elastic property measurement and single-cell multiomics, we will elucidate the biological and physical effects associated with ECM signaling and mechanotransduction at single-cell resolution (Aim 3). In summary, understanding the exact role and mechanism of ECM-cell interactions may contribute to finding new biomaterials or therapeutic modalities for treatment of heart diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Elucidating ECM Signaling in Cardiac Organoids with Machine Learning and Single-cell Multiomics
  • 批准号:
    10619622
  • 项目类别:
  • 资助金额:
    $62.08万
  • 财政年份:
    2022
  • 负责人:
    JAYAKUMAR RAJADAS
  • 依托单位:
Cardioprotective Therapy for Doxorubicin Using iPSC Microtissue and CRISPR Screening
  • 批准号:
    10463762
  • 项目类别:
  • 资助金额:
    $76.88万
  • 财政年份:
    2021
  • 负责人:
    JAYAKUMAR RAJADAS
  • 依托单位:
Cardioprotective Therapy for Doxorubicin Using iPSC Microtissue and CRISPR Screening
  • 批准号:
    10686024
  • 项目类别:
  • 资助金额:
    $59.57万
  • 财政年份:
    2021
  • 负责人:
    JAYAKUMAR RAJADAS
  • 依托单位:
Cardioprotective Therapy for Doxorubicin Using iPSC Microtissue and CRISPR Screening
  • 批准号:
    10296896
  • 项目类别:
  • 资助金额:
    $62.74万
  • 财政年份:
    2021
  • 负责人:
    JAYAKUMAR RAJADAS
  • 依托单位:
海外基金